Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.
Joanna GotfritRachel GoodwinTimothy AsmisAngela J HydeThierry AlcindorFrancine AubinScott BerryDominick BosseColin BrownRonald L BurkesMargot BurnellBruce ColwellJessica CorbettJeff CraswellNathalie DaaboulMark DohertyD A Barry FlemingLuisa GalvisRakesh GoelMohammed HarbAlwin JeyakumarDerek JonkerErin KennedyMichael LockAamer MahmudPatrick H McCreaVimoj NairRami NassabeinCarolyn NessimRavi RamjeesinghMuhammad RazaWissam SalibaSatareh SamimiSimron SinghStephanie L SnowMustapha TehféMichael ThirlwellMario ValdesStephen WelchMichael VickersPublished in: Current oncology (Toronto, Ont.) (2021)
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19-21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of anal, colorectal, biliary tract, and gastric cancers, including: radiotherapy and systemic therapy for localized and advanced anal cancer; watch and wait strategy for the management of rectal cancer; role of testing for dihydropyrimidine dehydrogenase (DPD) deficiency prior to commencement of fluoropyrimidine therapy; radiotherapy and systemic therapy in the adjuvant and unresectable settings for biliary tract cancer; and radiotherapy and systemic therapy in the perioperative setting for early-stage gastric cancer.
Keyphrases
- early stage
- papillary thyroid
- locally advanced
- squamous cell
- rectal cancer
- radiation therapy
- squamous cell carcinoma
- lymph node metastasis
- palliative care
- clinical practice
- south africa
- radiation induced
- childhood cancer
- high grade
- stem cells
- young adults
- drug induced
- cardiac surgery
- sentinel lymph node
- replacement therapy